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NEPHROLOGY

Distal Renal Tubular Acidosis and Diabetes Insipidus
Leading to the Diagnosis Of Sjögren's Syndrome
Loheetha Ragupathi, MD, Elijah Grillo, MD, Jonathan Yadlosky, MD, Ravi Sunderkrishnan, MD,
and Seyed Hamrahian, MD

INTRODUCTION
Sjögren's syndrome is a chronic inflammatory disease
characterized by the infiltration and progressive
destruction of salivary and lacrimal glands. A common
presentation involves the complaints of dry eyes and dry
mouth, known as the “sicca complex.” Extra-glandular
involvement is not uncommon, and is known to involve
the lungs, vascular and peripheral nervous system, and
kidney.1 The reported renal involvement ranges broadly
from 2 – 67%,and is variably defined: the most commonly
reported renal pathology is an a tubulo- interstitial nephritis
resulting in tubular dysfunction and immune-mediated
glomerular disease; however distal renal tubular acidosis
(RTA) in particular can be present in 20-30% of cases.2,3
Although there have been case reports of patients with
Sjögren's syndrome presenting with distal RTA during the
course of the disease, to our knowledge, a diagnosis of
Sjögren's syndrome made solely on the basis of renal
manifestations without any overt physical findings of the
disease has not been documented.

CASE PRESENTATION
A 37 year old female presented to another hospital with
progressive fatigue over the course of three months, and
debilitative weakness, nausea, and non-bloody non-bilious
vomiting over the course of one week. Her review of
systems was negative except for mild depression after
losing her job, for which she denied use of any psychiatric
medications. She was also eating a healthy and variable
diet with no change in appetite and no weight loss. She
did not have muscoloskeletal, cutaneous, or pulmonary
symptoms. Her past medical history included a deep vein
thrombosis and pulmonary embolism five years prior
following an airplane ride. Family history was significant
only for maternal type 2 diabetes mellitus.
Initial vital signs showed episodes of sinus bradycardia
responsive to atropine, and were otherwise within normal
limits. Physical examination showed profound bilateral
upper and lower extremity weakness, decreased reflexes
in all muscle groups, and absent Babinski’s sign. Laboratory
studies on admission showed the following: potassium
1.1 mEq/L, sodium 132 mEq/L, chloride 116 mEq/L,
bicarbonate of 9 mg/L, creatinine 2.6 mg/L, pH 7.07. A
urine drug screen was negative. Electrocardiogram
showed sinus bradycardia, flattened T waves, and U
waves (Figure 1). On the second day of admission, the
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Figure 1. Electrocardiogram shows flattened T waves and U waves

sodium level increased to 159 mEq/L. Her mental status
worsened, and she became obtunded. She was intubated
and mechanically ventilated.
Aggressive repletion of her potassium was initiated along
with fluid resuscitation with bicarbonate drip, lactated
ringers, and normal saline for her severe acidosis. A
therapeutic dose of low molecular weight heparin was
initiated due to incidentally found lower extremity deep
vein thrombosis on duplex ultrasound. Due to an
abnormal neurologic exam, a CT scan of the head was
performed which showed a pontine hemorrhage with
localized mass effect. She was subsequently transferred
to Thomas Jefferson University Hospital for management
of pontine hemorrhage and evolving electrolyte
abnormalities.
On further questioning of family members, the patient
had several months of increasing polyuria and polydipsia,
drinking 2-3 gallons of water a day and urinating every
two hours, including during the night. Further testing
revealed the following labs: serum osmolality 345 mOsm/
kg, urine osmolality 274 mOsm/kg, urine sodium 57
mEq/L, urine potassium 6 mEq/L, urine chloride 49
mEq/L, urine creatinine 19.7 mg/dL, urine pH 7.5. Renal
ultrasound showed bilateral increased cortical
echogenicity, suggestive of renal parenchymal disease.

INTERPRETATION AND DIAGNOSIS
This patient had a non-anion gap metabolic acidosis, and a
positive urine anion gap. Her urine pH was inappropriately
elevated. These values suggested a distal type renal tubular
acidosis. She was hypokalemic with an elevated transtubular
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Figure 2. Buccal biopsy section showing lymphocytic infiltrate, 40x magnification

Figure 3. Buccal biopsy with CD138 stain, showing an infiltrate of plasma cells

potassium gradient, suggesting renal losses as the cause for
her hypokalemia. The persistent hypernatremia, along with
inappropriately low urine osmolality correlate with diabetes
insipidus, which was likely compensated for by polydipsia in
the outpatient setting.

can lead to defects in the urine concentrating capacity,
which may cause partial nephrogenic diabetes insipidus.5
Renal manifestations of Sjögren's syndrome include acute
or chronic tubulointerstitial nephritis, immune-mediated
glomerular disease and less commonly, cryoglobulinemia, nephrocalcinosis and nephrogenic diabetes
insipidus.6

This combination of renal insufficiency, distal type renal
tubular acidosis and diabetes insipidus was suggestive of
tubulointerstitial disease. As there were no toxic drug
exposures, and no family history of renal disease, serologic
testing for autoimmune conditions was performed. High
titers of anti-nuclear, anti-SSa and anti-SSb antibodies
were found, suspicious for primary Sjögren's syndrome. A
biopsy of the salivary glands of the lip showed focal
lymphocytic sialadenitis (Figures 2 and 3), confirming the
diagnosis of Sjögren's syndrome.
Treatment with corticosteroids for Sjögren's disease was
initiated. Amiloride was initiated for treatment of
hypokalemia in addition to potassium supplements. Her
electrolyte levels normalized with these treatments. The
patient had a neurologic exam consistent with locked-in
syndrome and her neurologic prognosis was poor. Renal
biopsy was not performed due to improvement with
medical therapy, suggesting that there would be no
change in management with biopsy.

In patients with interstitial nephritis due to Sjögren's
disease, treatment modalities reported include steroids,
steroids with cyclophosphamide, and steroids with
azathioprine. The data available is scant, precluding an
analysis of the relative benefits of each modality.7 In our
patient, corticosteroids without other adjunctive immunosuppresive agents was used, with an adequate response.
In conclusion, in a patient with evidence of tubulointerstitial nephritis without underlying renal disease or other
etiology, it is important to recognize Sjögren's syndrome
as a possible
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